$HNGE

Robinson Elliott sold 0 shares of HNGE (indirect holdings)

Robinson Elliott sold 0 indirectly-held shares of Hinge Health, Inc. (HNGE) across 3 trades over 2026-06-10 to 2026-06-12.

Original reporting
SEC EDGAR · Robinson Elliott
Published Jun 12, 2026, 8:18 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 12, 2026, 8:21 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$HNGE
Neutral
high confidence
Mentioned
$HNGE
Relevance
2/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$HNGENeutralLow
01

Why it matters

While insider Form 4s can matter, this one reports 0 shares sold and 0 shares held after the transaction, limiting interpretability for trading flows.

02

Market read

A director’s Form 4 is disclosed, but the reported transaction size is 0 shares, suggesting negligible immediate trading significance.

03

What to watch

Because the transaction value and price are not disclosed and the share count is 0, traders should avoid inferring bearishness from the headline alone.

Relevance 2/10Novelty 2/10Timing: Filed 2026-06-12 (SEC Form 4)

Background

The article is an SEC EDGAR Form 4 insider transaction filing for Hinge Health, Inc. (HNGE).

Company-level read

Ticker impact

$HNGENeutralHigh confidence
Context

Robinson Elliott (director) filed an SEC Form 4 showing open-market sale transactions totaling 0 shares and ending with 0 shares held.

Expected impact

Minimal to no price impact expected; any effect would be limited to signaling/positioning rather than a tradable flow.

Evidence & confidence

The filing explicitly reports 0 shares across trades and 0 shares after the transaction, with no disclosed price or value, reducing materiality.

Market effects

No clear sector read-through; this is a single-insider Form 4 with zero-share execution.

None indicated.

None indicated.

Counterpoint

The 0-share outcome could reflect administrative/technical entries (e.g., plan mechanics or cancellations), so it may not represent any real selling pressure.

Key entities

  • Hinge Health, Inc.

    Company subject of the Form 4 insider transaction disclosure.

  • Robinson Elliott

    Director who reported the open-market sale transactions.

Related articles

$HNGEHighAI 9/10

Why is Hinge Health stock surging today?

Hinge Health (HNGE) shares rose 11.6% after the company reported Q2 2026 revenue of $212.8M (+53% YoY) and non-GAAP diluted EPS of $0.59 vs $0.13 consensus. Free cash flow exceeded $100M. Hinge raised FY2026 revenue guidance to $818M-$824M and Q3 guidance to $223M-$225M, and agreed to buy Cylinder Health for $105M cash. Analysts lifted price targets.